Three pharmaceuticals companies engaged an action for the annulment of a State ordinance which established emergency measures aiming at the re-establishment of the balance of social security consisting in exceptional contributions to be paid by pharmaceuticals companies. One of these contributions provides for a deduction, when calculating the amount of tax payable, of the expenses in France of
The French Administrative Supreme Court referred a case to the ECJ for a preliminary ruling on a tax deduction limited to expenditure on research carried out in the State of taxation (Baxter)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.